United Therapeutics (UTHR) Tops Q2 EPS by $1.14
Tweet Send to a Friend
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $3.63 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


